Published in Vaccine Weekly, January 18th, 2006
The current TB vaccine, BCG, does not provide good protection against pulmonary TB in adults or children. Aeras is working on a range of second-generation BCG vaccines with the aim of enhancing the protection they afford and introducing other improvements such as patient-friendly delivery options. As part of this program, Aeras has developed second-generation recombinant BCG strains...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly